OCEA Ocean Biomedical: Rasio rega marang prakiraan pendapatan
Ocean Biomedical, Inc. (OCEA) maintains business resilience through FDA patents and Brown University licenses. The forward price-to-sales ratio on GURU.Markets reflects the valuation trend, where represents the latest metric reading. The company relies on a closed-loop antibody system to combat cancer and malaria, attracting top researchers through a commercialization system for their scientific discoveries.
Rincian metrik lan analitis perusahaan Ocean Biomedical Corp (OCEA)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- data utang lan likuiditas:
Total Utang marang Modal Ocean Biomedical, Inc.|OCEA - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ocean Biomedical, Inc.|OCEA - Utang agregat perusahaan|Utang marang nilai buku Ocean Biomedical Corp|OCEA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ocean Biomedical|Rasio cepet oceanbiomedical.com
- rincian asil keuangan lan kelipatan valuasi:
OCEA - Asil keuangan resik|Bathi sing dikarepake Ocean Biomedical, Inc.|OCEA - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Ocean Bio|OCEA - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Ocean Biomedical Corp|OCEA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Ocean Biomedical|OCEA - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan oceanbiomedical.com|OCEA - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Ocean Biomedical, Inc.
- data dodolan lan asil:
Pambiji fundamental perusahaan:Ocean Biomedical (OCEA)
When constructing a long-term portfolio, it is critical to correlate market capitalization with expected revenue to determine an asset's degree of overvaluation. The forward P/S ratio measures a company's value relative to projected sales, which allows for an assessment of Ocean Biomedical, Inc. (OCEA) expansion potential in oncology through the scaling of B2B partnerships by tracking price momentum on this chart.
Pesaing wigati
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABVX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ADMA Corp|PTGX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan immunovant.com|KNSA (Kiniksa) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grifols SA GRFS|Multiplikator Forward P/S ADPT|Multiplikator Forward P/S Celldex Corp (CLDX)|Rasio rega marang prakiraan pendapatan Aurinia Pharmaceuticals AUPH|BCRX: Kapitalisasi marang prakiraan pendapatan|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics Inc)|PHVS: Multiplikator Forward P/S|ABCL (AbCellera Corp) - Rasio rega marang prakiraan pendapatan|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|precigen.com (PGEN) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Pharming Group (PHAR)|NKTR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Upstream Bio Corp UPB|ZBIO - Multiplikator forward rega marang pendapatan|Immunome, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep gossamerbio.com|KALV: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan SEPN|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|Savara Pharma (SVRA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan anaptysbio.com ANAB|Multiplikator Forward P/S ATXS (Astria Therapeutics, Inc.)|Multiplikator Forward P/S enGene Holdings Inc ENGN|RAPT - Rasio rega marang prakiraan pendapatan|JBIO: Rasio rega marang prakiraan pendapatan|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|kyvernatx.com - Rega forward marang dodolan|TLSA (Tiziana Life Sciences Ltd) - Multiplikator Forward P/S|Cabaletta Bio Inc. (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Ventyx Bio (VTYX)|Theratechnologies, Inc - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc)|ELDN - Multiplikator forward rega marang pendapatan|AGEN: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Climb Bio Inc. CLYM|Zura Bio Limited (ZURA) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep aTyr Pharmaceuticals (ATYR)|ADAG (Adagene Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Ikena Oncology, Inc. (IMA)|Multiplikator Forward P/S STTK|EQ - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S CNTB (Connect Biopharma Holdings Limited)|Multiplikator Forward P/S Immunic Therapeutics IMUX|ATRA - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan IFRX|XFOR: Multiplikator Forward P/S|Adicet Bio, Inc. - Rega forward marang dodolan|CELU (Celularity Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S INmune Bio Corporation|Rasio rega marang prakiraan pendapatan Barinthus Biotherapeutics (BRNS)|KZR (kezarlifesciences.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan SAB Biotherapeutics, Inc. SABS|AKTX - Multiplikator forward rega marang pendapatan|Enlivex Therapeutics, Ltd. - Multiplikator Forward P/S|QTTB - Multiplikator Forward P/S|GOVX (GeoVax Labs, Inc.) - Multiplikator forward rega marang pendapatan|edesabiotech.com - Rega forward marang dodolan|IBIO (iBio) - Multiplikator Forward P/S|Carisma Tx (CARM) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan XTL Biopharmaceuticals, Ltd. (XTLB)|Multiplikator forward rega marang pendapatan boltbio.com BOLT|Rasio rega marang prakiraan pendapatan HCW Biologics HCWB|APVO - Multiplikator forward rega marang pendapatan|AIM: Multiplikator forward rega marang pendapatan|ADTX - Multiplikator Forward P/S|GRI Bio Corp (GRI) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan XRTX|HIND (Vyome Holdings Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep revbiosciences.com REVB|Rasio rega marang prakiraan pendapatan Indaptus Therapeutics, Inc. (INDP)|SCNI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S CALI (CalciMedica)|AFMD - Multiplikator forward rega marang pendapatan|Allakos Therapeutics - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep HOOKIPA Pharma Inc.|IGMS: Multiplikator Forward P/S|iTeos Therapeutics Inc (ITOS) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Kapitalisasi marang prakiraan pendapatan THRD (Third Harmonic Bio Inc)
